PETS earnings

DELRAY BEACH, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its fourth quarter and fiscal year ended March 31, 2026.  Fourth Quarter Fiscal 2026 Financial Highlights Compared to Prior Year Period Net sales of $42.8 million compared to $50.8 million in the prior year period, a decrease of 15.6%, primarily driven by a decline in prescription medication sales.Net loss of $4.1 million, or $(0.19) per diluted share, compared to a net loss of $11.6 million, or $(0.56) per diluted share, for the prior year period. The decrease in the net loss can be attributed to lower general and

DELRAY BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) today announced it will report financial results for the fourth quarter and fiscal year ended March 31, 2026, on Tuesday, June 2, 2026 after market close. The Company will host a conference call and webcast to discuss these results at 4:30pm Eastern Time on the same day. Date: Tuesday, June 2, 2026Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562Webcast: 4Q Earnings Webcast A telephonic replay of the conference call will also be available after 7:30 PM Eastern Time on the same day through Jun

DELRAY BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced preliminary fourth quarter and fiscal year 2025 results and filed Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission. The Company is unable to file its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 within the prescribed time period without unreasonable effort or expense. The Company expects to file its Annual Report on Form 10-K with the Securities and Exchange Commission as soon as practicable, and no later than July 1, 2025, in accordance with Rule 12b-25. Preliminary Fourth Quarter

DELRAY BEACH, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced it is delaying the release of the Company's fourth quarter and fiscal year 2025 earnings release and subsequent conference call, which had been scheduled for June 10, 2025, because the Company requires additional time to complete the year-end audit process. The Company anticipates that it will issue the earnings release, hold the related conference call, and file its Annual Report on Form 10-K as soon as possible, but no later than June 16, 2025. About PetMed Express, Inc. Founded in 1996, PetMeds is a leader in pioneering the digital pet p

DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2025. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, June 10, 2025Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562We

DELRAY BEACH, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its third quarter ended December 31, 2024. Third Quarter Fiscal 2025 Financial Highlights Net sales of $53.0 million. Gross margin rate of 28.1%, an increase of 80 basis points compared to the prior year period. Adjusted EBITDA of $2.0 million compared to Adjusted EBITDA of $0.9 million in the prior year period. Continued progress on key initiatives supporting the transformation of the business. "In just nine months, we have made significant strides in our transformation journey, and I am pleased to report that

DELRAY BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Monday, February 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fiscal third quarter ended December 31, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Monday, February 10, 2025Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562Webcast

DELRAY BEACH, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its second quarter ended September 30, 2024. Second Quarter Fiscal 2025 Financial Highlights Net sales of $59.6 million.Gross margin of 29.1%, an increase of 0.8% compared to the prior year period.Net income of $2.3 million, or $0.11 per diluted share, compared to net income of $0.7 million, or $0.03 per diluted share, in the prior year period.  Adjusted EBITDA of $2.1 million improved sequentially from an Adjusted EBITDA loss of $(1.5) million in the first quarter of fiscal 2025 and compared to Adjusted EBITDA of $

DELRAY BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Wednesday, November 6, 2024 at 4:30pm Eastern Time to discuss its financial results for the fiscal second quarter ended September 30, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Wednesday, November 6, 2024Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8

DELRAY BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its first quarter ended June 30, 2024. Quarterly Highlights for Q1, Fiscal 2025 Net sales were $68 million, (13)% lower than the prior year comparable quarter.Net income was $3.8 million, or $0.18 diluted earnings per share. This compares to net loss of $(1.1) million, or $(0.06) diluted earnings per share, for the prior year comparable quarter.Increase in net income is primarily attributed to a $8.7 million reversal of accumulated stock compensation expense associated with departure of the former CEO, partially off

DELRAY BEACH, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Tuesday, August 6, 2024 at 4:30pm Eastern time to discuss its financial results for the fiscal first quarter ended June 30, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, August 6, 2024Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 844-826-3035International number: 412-317-5195Webcast: 1Q Ear

DELRAY BEACH, Fla., June 11, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its fourth quarter and fiscal year ended March 31, 2024.  Quarterly Highlights Net sales for the quarter ended March 31, 2024, were $66.5 million, compared to $62.4 million for the fourth quarter in the prior year, an increase of 6.6%, driven by the acquisition of PetCareRx partially offset by a decline in PetMeds legacy sales.Net loss for the quarter ended March 31, 2024 was $(5.0) million, or $(0.25) diluted earnings per share. This compares to net loss of $(0.2) million, or $(0.01) diluted earnings per share, for

DELRAY BEACH, Fla., May 22, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) ("PetMeds"), will hold a conference call on Tuesday, June 11, 2024 at 4:30pm Eastern time to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, June 11, 2024Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 877-407-0789International number: 2

Fiscal 2024 3Q Revenue of $65.3 million, an 11% increase compared to last year including PetCareRx results.AutoShip & Save and PetPlus Membership, 52% of total revenue, up from 42% at the same time last year.Strong balance sheet with $49.4 million of cashThe Company is now current in all of its SEC filings DELRAY BEACH, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS)("PetMeds" or "Company"), Your Trusted Pet Health ExpertTM, today announced its financial results for its third quarter of fiscal year 2024, restated financial statements for the years ended March 31, 2023, 2022 and 2021, and interim financial statements for previously reported quarterly periods in

DELRAY BEACH, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) ("PetMeds" or the "Company"), Your Trusted Pet Health ExpertTM, today announced its selected preliminary financial results for its third quarter ended December 31, 2023. These preliminary financial results are unaudited, based on currently available information and do not present all necessary information for a complete understanding of the Company's financial condition as of December 31, 2023 or its results of operations for the quarter ended December 31, 2023. Quarterly Highlights Net sales for the quarter ended December 31, 2023, are expected to be $65.3 million, compared to $58.9 million for the

DELRAY BEACH, Fla., Jan. 29, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) (the "Company"), Your Trusted Pet Health ExpertTM will hold a conference call on Thursday, February 8, 2024 at 4:30pm Eastern time to discuss its financial results for the fiscal third quarter ended December 31, 2023. Financial results will be issued in a press release prior to the call. PetMeds' management will host the conference call, followed by a question and answer period. Date: Thursday, February 8, 2024Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 877-407-0789 International number: 201-689-8562Webcast: 3Q Webcast Link Please call the conference telephone number 5-10 mi

DELRAY BEACH, Fla., Oct. 19, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) (the "Company"), Your Trusted Pet Health ExpertTM will hold a conference call on Monday, October 30, 2023 at 4:30pm Eastern time to discuss its financial results for the fiscal second quarter ended September 30, 2023. Financial results will be issued in a press release prior to the call. PetMeds' management will host the conference call, followed by a question and answer period. Date: Monday, October 30, 2023Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 877-407-0791 International number: 201-689-8563Webcast: 2Q Webcast Link Please call the conference telephone number 5-10 m

DELRAY BEACH, Fla., July 31, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) ("PetMeds" or "Company"), Your Trusted Pet Health Expert™, today announced its financial results for its first quarter ended June 30, 2023.  Quarterly Highlights Net sales for the quarter ended June 30, 2023, were $78.2 million, compared to $70.2 million for the first quarter in the prior year, an increase of 11.5%. PetMeds reported an increase in new customers of 25% year over year for the quarter ended June 30, 2023, representing the third consecutive quarter of new customer growth. This includes new customers from the PetCareRx acquisition.Net loss for the quarter ended June 30, 2023 was $(0.9) mi

DELRAY BEACH, Fla., July 17, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) (the "Company"), Your Trusted Pet Health Expert™ will hold a conference call on Monday, July 31, 2023 at 4:30pm Eastern time to discuss its financial results for the fiscal first quarter ended June 30, 2023. Financial results will be issued in a press release prior to the call. PetMeds' management will host the conference call, followed by a question and answer period. Date: Monday, July 31, 2023Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 877-407-0789 International number: 201-689-8562Webcast: 1Q Webcast Link Please call the conference telephone number 5-10 minutes prior to t

DELRAY BEACH, Fla., May 22, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS), Your Trusted Pet Health Expert™, today announced its financial results for its fourth quarter and fiscal year ended March 31, 2023. Quarterly Highlights Net sales for the quarter ended March 31, 2023, were $62.4 million, compared to $66.0 million for the fourth quarter in the prior year, a decrease of 5.4%. New customers increased 12% year over year for the quarter ended March 31, 2023 representing the second consecutive quarter of quarterly year-over-year new customer growth following a 2 ½ year period without such growth.Net loss for the quarter ended March 31, 2023 was $(5.1) million, or $(0.25) d

DELRAY BEACH, Fla., May 08, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (PETS) (the "Company"), Your Trusted Pet Health Expert™ will hold a conference call on Monday, May 22, 2023 at 4:30pm Eastern time to discuss its financial results for the fourth quarter and full year ended March 31, 2023. Financial results will be issued in a press release prior to the call. PetMeds' management will host the conference call, followed by a question and answer period. Date: Monday, May 22, 2023Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 877-407-0789 International number: 201-689-8562Webcast: 4Q Earnings Webcast Please call the conference telephone number 5-10 minutes prior to

DELRAY BEACH, Fla., Feb. 06, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS), Your Trusted Pet Health Expert™, today announced its financial results for its third quarter ended December 31, 2022.  Quarterly Highlights Net sales for the quarter ended December 31, 2022, were $58.9 million, compared to $60.7 million for third quarter in the prior year, a decrease of 3.0%. PetMeds® reports new customers increased 9% year over year for the quarter ended December 31, 2022 representing the first customer increase in 2 ½ years.Net loss for the quarter ended December 31, 2022 was $19.0 thousand, or $(0.0) diluted earnings per share or $0.02 per diluted share excluding the effects of c

DELRAY BEACH, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (PETS) (the "Company"), Your Trusted Pet Health Expert™ will hold a conference call on Monday, February 6, 2023 at 4:30pm Eastern time to discuss its financial results for the third quarter ended December 31, 2022. Financial results will be issued in a press release prior to the call. PetMed management will host the conference call, followed by a question and answer period. Date: Monday, February 6, 2023Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 877-407-0789 International number: 201-689-8562Webcast: PetMeds Q3 Earnings Webcast Please call the conference telephone number 5-10 minutes prio

DELRAY BEACH, Fla., Jan. 17, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS), Your Trusted Pet Health Expert™, has reached a definitive agreement to acquire PetCareRx, a leading supplier of pet medications, food, and supplies. The combined entities will expand PetMeds' existing base of over two million customers and will add approximately 10,000 incremental wellness products to the company's existing product offering. The acquisition of PetCareRx gives PetMeds an immediate revenue boost, and the company believes it can expand on that growth through an expanded product catalog and differentiated services. "We believe this acquisition will not only be highly benefi

DELRAY BEACH, Fla., Nov. 07, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS), Your Trusted Pet Health ExpertTM, today announced its financial results for its second quarter ended September 30, 2022.  Quarterly Highlights Net sales for the quarter ended September 30, 2022, were $65.4 million, compared to $67.4 million for second quarter in the prior year, a decrease of 3.0%. Net income for the quarter ended September 30, 2022 was $2.6 million, or $0.13 diluted earnings per share, and includes $1.3 million, or $0.05, per diluted share for two items not indicative of our ongoing operations. This compares to net income of $6.3 million, or $0.31 diluted earnings per share,

DELRAY BEACH, Fla., Oct. 20, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (PETS) (the "Company"), Your Trusted Pet Health ExpertTM, will hold a conference call on Monday, November 7, 2022 at 4:30pm Eastern Time to discuss its financial results for the second quarter ended September 30, 2022. Financial results will be issued in a press release prior to the call. PetMed Express management will host the conference call, followed by a question and answer session. Date: Monday, November 7, 2022Time: 4:30 Eastern Time (1:30 Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562 The Company will also provide a link at https://www.1800petmeds.com/investor.html f

DELRAY BEACH, Fla., July 25, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS), Your Trusted Pet Health ExpertTM, today announced its financial results for its first quarter ended June 30, 2022. Net sales for the quarter ended June 30, 2022, were $70.2 million, compared to $79.3 million for first quarter in the prior year, a decrease of 11.5%. Net income for the quarter ended June 30, 2022 was $2.8 million, or $0.14 diluted earnings per share, compared to net income of $4.4 million, or $0.22 diluted earnings per share, for the prior year quarter ended June 30, 2021. Adjusted EBITDA (1) was $6.3 million, or $0.31 diluted earnings per share, for the current year quarter, compared t

DELRAY BEACH, Fla., July 11, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) will announce its financial results for the quarter ended June 30, 2022, on Monday, July 25, 2022, at 4:00 P.M. Eastern Time, then at 4:30 P.M. Eastern Time, the Company will host a conference call to review the financial results. To access the call, which is open to the public, please dial (877) 407-0789 (toll free) or (201) 689-8562, ten minutes prior to the scheduled start time, and all callers will be placed on hold until the call begins at 4:30 P.M. Eastern Time. We will also provide a link at https://www.1800petmeds.com/investor.html for those who wish to stream the call via webcast. For those

DELRAY BEACH, Fla., May 09, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) today announced its financial results for the quarter and fiscal year ended March 31, 2022. Net sales for the quarter ended March 31, 2022, were $66.0 million, compared to $71.7 million for the comparable quarter in the prior year, representing a decrease of 7.9%. Net income of $6.1 million, or $0.30 diluted earnings per share, for the quarter ended March 31, 2022, declined 11% from net income of $6.8 million, or $0.34 diluted earnings per share, for the prior year quarter ended March 31, 2021. Adjusted EBITDA (1) was $9.5 million, or $0.47 diluted per share, for the current year quarter, compared to ad

DELRAY BEACH, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) will announce its financial results for the quarter and year ended March 31, 2022, on Monday, May 9, 2022, at 4:00 P.M. Eastern Time, then at 4:30 P.M. Eastern Time, the Company will host a conference call to review the financial results. To access the call, which is open to the public, please dial (800) 891-8256 (toll free) or (415) 226-5361, ten minutes prior to the scheduled start time, and all callers will be placed on hold until the call begins at 4:30 P.M Eastern Time. We will also provide a link at https://www.1800petmeds.com/investor.htmlpetmeds.com/investor.html for those who wish to stream th

DELRAY BEACH, Fla., Jan. 24, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) today announced its financial results for the quarter ended December 31, 2021. Net sales for the quarter ended December 31, 2021, were $60.7 million, compared to $65.9 million for the quarter ended December 31, 2020, a decrease of 7.9%. Net sales for the nine months ended December 31, 2021, were $207.4 million, compared to $237.5 million for the nine months ended December 31, 2020, a decrease of 12.7%. Net income was $4.3 million, or $0.21 diluted per share, for the quarter ended December 31, 2021, compared to net income of $7.6 million, or $0.38 diluted per share, for the quarter ended December 31, 20

DELRAY BEACH, Fla., Jan. 18, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) will announce its financial results for the quarter ended December 31, 2021, on Monday, January 24, 2022, at 4:00 P.M. Eastern Time, then at 4:30 P.M. Eastern Time, the Company will host a conference call to review the financial results. To access the call, which is open to the public, please dial (877) 407-0789 (toll free) or (201) 689-8562, ten minutes prior to the scheduled start time, and all callers will be placed on hold until the call begins at 4:30 P.M Eastern Time. We will also provide a link at https://www.1800petmeds.com/investor.html for those who wish to stream the call via webcast.

DELRAY BEACH, Fla., Oct. 25, 2021 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) today announced its financial results for the quarter ended September 30, 2021. Net sales for the quarter ended September 30, 2021 were $67.4 million, compared to $75.4 million for the quarter ended September 30, 2020, a decrease of 10.7%. Net sales for the six months ended September 30, 2021 were $146.7 million, compared to $171.6 million for the six months ended September 30, 2020, a decrease of 14.5%. Net income was $6.3 million, or $0.31 diluted per share, for the quarter ended September 30, 2021, compared to net income of $8.4 million, or $0.42 diluted per share, for the quarter ended September 30

DELRAY BEACH, Fla., Oct. 18, 2021 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) will announce its financial results for the quarter ended September 30, 2021 on Monday, October 25, 2021 at 4:00 P.M. Eastern Time, then at 4:30 P.M. Eastern Time, the Company will host a conference call to review the financial results. To access the call, which is open to the public, please dial (877) 407-0789 (toll free) or (201) 689-8562, ten minutes prior to the scheduled start time, and all callers will be placed on hold until the call begins at 4:30 P.M Eastern Time. We will also provide a link at https://www.1800petmeds.com/investor.html for those who wish to stream the call via webcast. For t

DELRAY BEACH, Fla., July 26, 2021 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) today announced its financial results for its first quarter ended June 30, 2021. Net sales for the quarter ended June 30, 2021 were $79.3 million, compared to $96.2 million for the quarter ended June 30, 2020, but relatively flat versus the quarter ended June 30, 2019, prior to the pandemic. Net income for the quarter ended June 30, 2021 was $4.4 million, or $0.22 diluted per share, compared to net income of $7.8 million, or $0.39 diluted per share, for the same quarter the prior year, and $5.3 million or $0.26 for the quarter ended June 30, 2019. During the quarter ended June 30, 2021 there were one-t

DELRAY BEACH, Fla., July 19, 2021 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) will announce its financial results for the quarter ended June 30, 2021 on Monday, July 26, 2021 at 8:00 A.M. Eastern Time, then at 8:30 A.M. Eastern Time, the Company will host a conference call to review the financial results. To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (203) 827-7025, ten minutes prior to the scheduled start time. Callers will be required to supply PETMEDS as the passcode, and will be placed on hold with music until the call begins. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M

8.8% Increase in Fiscal 2021 Sales18.4% Increase in Fiscal 2021 Net Income9.7% Increase in Fiscal 2021 Reorder Sales DELRAY BEACH, Fla., May 03, 2021 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) today announced its financial results for its fourth quarter and fiscal year ended March 31, 2021. Net sales for the year ended March 31, 2021 were $309.2 million, compared to $284.1 million for the year ended March 31, 2020, an increase of 8.8%. Net income for the year ended March 31, 2021 was $30.6 million, or $1.52 diluted per share, compared to net income of $25.9 million, or $1.29 diluted per share, for the prior year, an increase to net income of 18.4%. Reorder sales for the year e

Quarterly Sales Increased 10% Diluted EPS increased from $0.34 to $0.38 per share Quarterly Average Order Size increased to $88 DELRAY BEACH, Fla., Jan. 19, 2021 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended December 31, 2020. Net sales for the quarter ended December 31, 2020 were $65.9 million, compared to $59.9 million for the quarter ended December 31, 2019, an increase of 10.0%. Net sales for the nine months ended December 31, 2020 were $237.5 million, compared to $209.8 million for the nine months ended December 31, 2019, an increase of 13.2%. Net income was $7.6 million, or $0.38 diluted per share, for the quart